Close
Nordic 9Nordic 9

Athernal Bio (private company)

United Kingdom athernalbio.com
See something wrong or missing? Let us know
Offices:Cambridge
Industry:BiotechHealth servicesPharma
Business model:B2B

Athernal Bio is a British startup developing targeted immunotherapies for high-risk clonal haematopoiesis

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 4.72M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Athernal Bio

Name Criteria
Sweden Athera
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Poland Biotts
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Oui
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Pulmobiotics S.L
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Finland Brinter
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Colzyx
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Netherlands CimCure
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mable
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top